Robuta

https://pubmed.ncbi.nlm.nih.gov/26815195/
In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues...
identificationinhibitorcpibromodomain
https://www.ncbi.nlm.nih.gov/Structure/pdb/9F1K
Bromodomain-containing protein 41,2-ETHANEDIOL
firstbromodomaincomplexdual
https://pubmed.ncbi.nlm.nih.gov/30192303/?dopt=Abstract
Inhibition of BRAF improves therapeutic efficacy of BRAF-mutant melanoma. However, drug resistance to BRAF inhibitor is inevitable, and the drug resistance...
the betbromodomain inhibitordrug resistancemitigatesvemurafenib
https://www.ncbi.nlm.nih.gov/Structure/pdb/5LPJ
CREB-binding protein~{N}-[(3-chlorophenyl)methyl]-4-ethanoyl-3-ethyl-5-methyl-1~{H}-pyrrole-2-carboxamide
crystal structurebromodomainhumancrebbpbound
https://www.ncbi.nlm.nih.gov/Structure/pdb/8GA2
CREB-binding protein(6S)-6-{(5M)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(1s,4R)-4-methoxycyclohexyl]-1H-benzimidazol-2-yl}-1-phenylpiperidin-2-one1,2-ETHANEDIOL
bromodomaincbpinhibitor
https://www.ncbi.nlm.nih.gov/Structure/pdb/5TI3
Bromodomain-containing protein 41,2-ETHANEDIOL2,5-dibromo-N-[3-(2-oxopyrrolidin-1-yl)phenyl]benzene-1-sulfonamide
crystal structurethe firstbromodomainhuman